AzTrials
AzTrials

DepressionEarly Phase 1ShareITNCT01423448

Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial

A Early Phase 1 study testing bulletin board in people with Depression, run by Louise Farrer at 1 site in Australia.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study is a randomised controlled trial that aims to examine the efficacy of an established online bulletin board for depression. It has been estimated that millions of people worldwide use peer-to-peer bulletin boards, forums or internet support groups (ISGs) for health conditions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Depression
What is being tested?
bulletin board
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteAustralia
Study dates
Start not givento not given
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Over 18 years of age
  • Internet access with email
  • Self-report of current or previous experience of depression

Who cannot join

  • Current participation in an online support group for depression
  • Diagnosis of bipolar disorder, schizophrenia, or psychosis

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Centre for Mental Health Research, The Australian National University

    Canberra, Australian Capital Territory, 0200

Other trials in Australia

About this study

Official title: A Randomized Controlled Trial of an Online Bulletin Board for Depression

This study is a randomised controlled trial that aims to examine the efficacy of an established online bulletin board for depression. It has been estimated that millions of people worldwide use peer-to-peer bulletin boards, forums or internet support groups (ISGs) for health conditions. However, little is known about the effectiveness of these groups in terms of symptom reduction or improvement in quality of life. The current project investigates the effectiveness of an established online bulletin board for depression available to the public. To our knowledge, this is the first randomised controlled trial of the effectiveness of a pre-existing, well-established online bulletin board for depression in the community. The aims of the project are to determine whether the bulletin board improves mental health, quality of life, and related outcomes among members of the community with high levels of self-reported psychological distress and previous history or current experience of depression.

Conditions
Depression
Being tested
bulletin board
Keywords
Depression, mental health, wellbeing, online bulletin board, online support group
Medical subject headings
Depression, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bulletin boardOther

    An asynchronous online bulletin board for people with experience of depression

Study groups in NCT01423448
Study groupRoleWhat they receive
Bulletin boardExperimentalParticipants will be given access to the online bulletin board (intervention) for a 6 month period
Receives: Other: bulletin board
ControlNo interventionAfter 6 months participants allocated to the control group will receive access to the intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depressive symptoms: Centre for Epidemiological Studies - Depression Scale (CES-D)

    20-item self -report measure of depression severity

    Measured: Baseline

  2. Depressive symptoms: Centre for Epidemiological Studies - Depression Scale (CES-D)

    20-item self -report measure of depression severity

    Measured: 6 months post-baseline

  3. Depressive symptoms: Centre for Epidemiological Studies - Depression Scale (CES-D)

    20-item self -report measure of depression severity

    Measured: 12 months post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2011 (estimated)

Why it stopped: Recruitment of participants did not commence due to lack of available staff to run the trial.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01423448
Sponsor's protocol ID
CMHR-123
Other IDs
NHMRC Fellowship ref 525413
Acronym
ShareIT
Status last verified
Jan 2015
First submitted
23 Aug 2011
Last updated
14 Jan 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing bulletin board in people with Depression, run by Louise Farrer at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 14 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depressive symptoms: Centre for Epidemiological Studies - Depression Scale (CES-D) (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in